Vysis' PathVysion HER-2 Test Ships Dec. 18 At Premium To Dako's HercepTest
This article was originally published in The Gray Sheet
Executive Summary
Vysis is betting that its fluorescence in situ hybridization (FISH)-based PathVysion HER-2 DNA probe kit justifies a significantly higher price than Dako's immunohistochemistry-based HercepTest.